GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,379,244 | -31.1% | 8,279,484 | 0.0% | 4.86% | -14.2% |
Q2 2023 | $45,537,162 | +27.9% | 8,279,484 | 0.0% | 5.67% | +17.6% |
Q1 2023 | $35,601,781 | +9.4% | 8,279,484 | +0.0% | 4.82% | +23.0% |
Q4 2022 | $32,535,983 | -26.0% | 8,278,876 | 0.0% | 3.92% | -19.2% |
Q3 2022 | $43,961,000 | -19.1% | 8,278,876 | 0.0% | 4.85% | -46.6% |
Q2 2022 | $54,309,000 | -10.6% | 8,278,876 | 0.0% | 9.08% | +18.2% |
Q1 2022 | $60,767,000 | +3.7% | 8,278,876 | 0.0% | 7.68% | +42.7% |
Q4 2021 | $58,614,000 | – | 8,278,876 | – | 5.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |